All In Biotech

NDA 019127 · Xttrium

Exidine

Chlorhexidine Gluconate · Topical

Last checked: Nov 20, 2026Latest source record: May 27, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1984

Dec 24, 1984

Approved uses

1

Original approval plus efficacy supplements

Registered trials

551

112 Phase 3, 30 recruiting

FAERS reports

7,712

6,493 serious, 2,709 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Apr 30, 2026.

Uses  surgical hand scrub: significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care  healthcare personnel handwash: helps reduce bacteria that potentially can cause disease

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Dec 24, 1984 Original approval · Type 3 - New Dosage Form
1 products under this application
  • EXIDINE · CHLORHEXIDINE GLUCONATE 4% · AEROSOL, METERED, TOPICAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Chlorhexidine Gluconate" as an intervention, any sponsor and status, largest first.

All 551 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • fatigue1,899
  • joint swelling1,721
  • rash1,694
  • hypersensitivity1,663
  • impaired healing1,631
  • folliculitis1,619
  • weight increased1,608
  • pain1,585
  • stomatitis1,569
  • arthralgia1,554
  • lower respiratory tract infection1,543
  • glossodynia1,530

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200428
200519
200620
200738
200889
200995
2010151
2011160
2012163
201364
201483
2015131
2016235
2017268
2018297
2019310
2020402
2021676
2022602
2023507
20241,322
20251,535
2026517

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 571 on PubMed

Sponsor: Xttrium

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.